David Krane

Solo Angel AI focus San Francisco, CA, United States

About David Krane

David Krane is CEO of GV (formerly Google Ventures) and angel-invests from San Francisco at $250k+ checks at seed and Series A, with a healthcare focus on AI/ML in healthcare and health IT software. His positioning as the head of GV makes a personal angel check effectively a high-conviction signal, and his early Google operating background gives him strong instincts on AI-native software companies. Founders building AI-first healthcare software, infrastructure for clinical and administrative workflows, or platforms that benefit from Google-ecosystem relationships are the natural fit. The check size is meaningful enough to be a credible signal in any round, and the GV affiliation often opens doors to follow-on capital and strategic relationships across Alphabet. He is not the right audience for biotech, devices, or healthcare companies without a strong software and data spine. As with most senior platform GPs, cold outreach has near-zero yield; founders should invest in warm introductions through GV portfolio CEOs, the broader Google alumni network, or top-tier seed funds that frequently co-invest with GV. LinkedIn is the right channel only if there’s a credible mutual connection. Diligence will be rigorous and metrics-fluent, so come with a clear product, traction story, and articulated AI defensibility rather than a thesis-only narrative.

Founder reviews

No founder reviews yet. Raised from this fund? Share your experience with other founders.

Healthcare AI tools backed by David Krane

Tools made by companies in David Krane's portfolio that we cover in the directory.

23andMe Personal Genome Service (PGS) Genetic Health Risk Test for Hereditary Thrombophilia
23andMe
Clinical Decision Support & Reference
The 23andMe Personal Genome Service (PGS) Genetic Health Risk Test for Hereditary Thrombophilia is an FDA-cleared direct-to-consumer genetic test that identifies specific genetic variants (Factor V Leiden and Prothrombin G20210A) associated with an increased risk of developing harmful blood clots. It provides personal genetic insights for proactive health discussions with healthcare professionals.
Flatiron Health OncologyCloud
Flatiron Health
Clinical Decision Support & Reference
Flatiron Health is a healthtech company expanding the possibilities for point of care solutions in oncology and using data for good to power smarter care for every person with cancer.
FoundationOne
Foundation Medicine
Drug Discovery & Research
FoundationOne offers FDA-approved, AI-assisted comprehensive genomic profiling for solid tumors, helping physicians inform cancer treatment and identify clinical trial opportunities.
Lyra Health
Lyra Health
Mental & Behavioral Health AI
Lyra Health offers a comprehensive global mental health care solution, leveraging clinically rigorous AI to provide fast access to therapy, coaching, psychiatry, and specialty care, connecting individuals with a vast network of providers and supporting employers, health plans, and health systems.
Insitro
Insitro
Drug Discovery & Research
Insitro combines automated cellular experiments with population-scale genetics to build Physical AI systems that reveal causal drivers of human disease and deliver targeted therapeutics.

Portfolio companies in our directory

Flatiron Health
EMR / EHR Platform Healthcare Analytics / BI
New York, NY, USA
1 tool in directory
$250M+
Flatiron Health is a leading healthtech company dedicated to transforming cancer care and accelerating research through advanced clinical…
Clinical Decision Support & Reference Oncology AI
23andMe
Biotech / Drug Discovery Clinical AI Platform
South San Francisco, California, U.S.
1 tool in directory
$250M+
23andMe, founded in 2006, has transitioned from a pioneering direct-to-consumer (DTC) genetic testing company into a multifaceted genomics…
Clinical Decision Support & Reference Lab & Diagnostics
Foundation Medicine
Point-of-Care Diagnostics Specialty-Focused AI
Boston, Massachusetts, United States (specifically, 400 Summer Street, Boston's Seaport District)
1 tool in directory
$50M–$250M
Foundation Medicine is a global, patient-focused precision medicine company dedicated to transforming cancer care through comprehensive genomic profiling…
Drug Discovery & Research Oncology AI Pathology AI
Lyra Health
Mental Health Platform Telehealth Network
Burlingame, CA
1 tool in directory
$250M+
Lyra Health is a leading digital mental health company that partners with employers and health plans to provide…
Mental & Behavioral Health AI Telehealth & Virtual Care
Insitro
AI Research Lab Biotech / Drug Discovery
South San Francisco, CA, United States
1 tool in directory
$250M+
Insitro is a biotechnology company that leverages machine learning (ML) and high-throughput biology to revolutionize drug discovery and…
Drug Discovery & Research Lab & Diagnostics

Other portfolio companies

Companies in David Krane's portfolio not currently in our directory.

Team

David Krane
CEO & Managing Partner
LinkedIn
Krishna Yeshwant
Managing Partner
LinkedIn
Cathy Friedman
Special Advisor
LinkedIn
Blake Byers
General Partner
LinkedIn
Frederique Dame
General Partner
LinkedIn

Pitch / review this investor

Have you raised from David Krane? Founders only — share your honest experience (anonymous OK, moderated before publishing).

Share your experience
Last updated 2026-05-06. Sourced from this fund's published materials.
AI Tool Finder
AI-powered search. Results may not be comprehensive.